97 results found.
        
NuVasive Reports 3Q16 Revenue
NuVasive reported 3Q16 revenue of US $239.6MM, +19.5% from 3Q15. (U.S. $208.3MM, +18.1%; ex-U.S. $31.4MM, +29.8%)...
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
NuVasive Reports 2Q16 Revenue
NuVasive reported 2Q16 revenue of US $236.2MM, +16.4% from 2Q15. (U.S. $200.5MM, +12.7%; ex-U.S. $35.6MM, +43.6%)...
NuVasive Reports 1Q16 Revenue
NuVasive reported 1Q16 revenue of US $215.1MM, +11.8% from 1Q15. (U.S. $186.4MM, +11.1%; ex-U.S. $28.7MM, +16.7%)...
Company Revenue 2015: NuVasive
Download the March issue of ORTHOKNOW for a graphical presentation of 2015 company performance. 2015: $811.1MM, +8.2%
NuVasive Posts 4Q15/2015 Revenue
NuVasive (NUVA) posted 4Q15 revenue of US $215.3MM, +6.8% vs. 4Q14, and 2015 revenue of $811.1MM, +8.2% from 2...
NuVasive Reports Preliminary 4Q15 and 2015 Revenue
NuVasive announced preliminary unaudited 2015 revenue of ~US $811MM, +8% from 2014, and 4Q15 revenue of ...
NuVasive 3Q15 Revenue Up 7.8% CC vs. 3Q14
NuVasive posted 3Q15 revenue of US $200.5MM, +5.6% as reported and +7.8% in constant currency, and YTD 2015 re...
BARE BONES® - July 28, 2015
NuVasive announced 2Q15 revenue of US $202.9MM, +8.5% from 2Q14. Growth reflects constant currency. (NuVasive, Inc., 7/28/15)
BARE BONES® - May 4, 2015
NuVasive announced 1Q15 revenue of US $192.4MM, +10% from 1Q14. Growth reflects constant currency. (NuVasive, Inc., 5/4/15)
BARE BONES® - February 25, 2015
NuVasive announced 4Q14 revenue of US $204.3MM, +7.1% vs. 4Q13, and 2014 revenue of $762.4MM, +11.6% vs. 2013. (
2014 Revenue: NuVasive
4Q14 revenue: $204.3MM, +7% (Ex-U.S. +36%; U.S. Lumbar +4%, U.S. Cervical +5%) Biologics +9% Monitoring Service -4% Precept posterior fixation surpassed $100MM in cumulative sales since launch   2014 reve...
BARE BONES® - January 12, 2015
NuVasive announced preliminary 4Q14 revenue of ~US $203MM and preliminary 2014 revenue of ~$761MM, >12% constant currency growth vs. 2013. (
BARE BONES® - October 30, 2014
NuVasive announced 3Q14 revenue of US $189.9MM, +12.3% from 3Q13. (NuVasive, Inc., 10/30/14)
3Q14 Revenue: NuVasive
$189.9MM, +12% (ex-U.S. +45%) U.S. Lumbar +8% U.S. Biologics +13% U.S. Cervical -2% U.S. IOM Service +14%   Price pressure less than -2%, consistent with previous quarters Mo...
BARE BONES® - July 29, 2014
NuVasive announced 2Q14 revenue of US $190.7MM, +15.1% from 2Q13. (NuVasive, Inc., 7/29/14)
2Q14 Revenue: NuVasive
$190.7MM, +15% (U.S. $167.0MM, +10%; ex-U.S. $23.6MM, +56%) Spine Surgery $147.3MM, +14% Biologics $32.8MM, +18% Monitoring Service $10.5MM, +15%   U.S. growth: Lumbar +10%, Biologics +18%, Cervical -1%, ...
BARE BONES® - April 29, 2014
NuVasive announced 1Q14 revenue of US $177.5MM, +11.3% from 1Q13. (NuVasive, Inc., 4/29/14...
1Q14 Revenue: NuVasive
$177.5MM, +11% (Ex-U.S. +34%) U.S. Lumbar +8% U.S. Biologics +9% U.S. Cervical +9% U.S. Monitoring +11%   International driven by strong growth in Europe, Asia Pacific, offset by economy in...
BARE BONES® - March 3, 2014
NuVasive reported 4Q13 revenue of US $190.8MM, +15.1% from 4Q12, and 2013 revenue of $685.2MM, +10.5% from 2012. (
4Q13/2013 Revenue: NuVasive
4Q13 revenue: $190.8MM, +15% (Ex-U.S. +40 U.S. Lumbar +12% U.S. Cervical +17% U.S. Biologics+12% Impulse Monitoring +15%   2013 revenue: $685.2MM, +11% (Ex-U.S. >$70MM, +30%+) ...
BARE BONES® - January 15, 2014
NuVasive announced preliminary 4Q13 revenue of ~US $189MM, +14% from 4Q12, and preliminary 2013 revenue of ~$683MM, >10% growth vs. 2012. (
BARE BONES® - October 29, 2013
NuVasive announced 3Q13 revenue of US $169.2MM, +14% from 3Q12. (NuVasive, Inc., 10/29/13)
3Q13 Revenue: NuVasive
$169.2MM, +14% (Ex-U.S. +31%) U.S. lumbar +12%, supported by Precept, MAS, PLIF, XLIF U.S. biologics +11%, driven by strong lumbar procedure volume U.S. cervical +27% U.S. monitoring -4%, affected by reimbursement challenges...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group